- Action Alerts PLUS - $50 off
- Financial Advisor Update
- Free Portfolio Tool
- Calculators
- Mobile(NEW)
- Stockpickr
- Stockpickr Answers
- Geezeo Personal Finance
- Mad Money Performance
- TSC Ratings
- Stock Screener
- Mutual Fund Screener
- ETF Screener
- Banks & Thrifts Screener
- Insurers & HMOs Screener
- Glossary
- Horo$copes
TheStreet: Stock Quotes, Financial Market News, & Investment Advice
Top Stories
Wall Street Bulls Take the Win
After some early volatility, stocks in New York close Tuesday with gains as investors shake off the latest economic data. Frank Curzio reviews the action in The Real Story video (above).
Don't Miss
Hedge Fund Hell: Fortress Under Siege Cramer's 'Mad Money' Recap: China's Big Stimulus to the Rescue 'Fast Money' Recap: Tech Stocks Show Some Life Update: Alcoa Slashes Jobs, Cuts Output Cramer: Best Name in Tech
BofA's Lewis Declines Bonus: Report
Delving Into Dow Chemical's Strategy
LyondellBasell Units File For Bankruptcy
F5 Shares Up Despite Lowered Estimates
Apple's Macworld Finale Short on Fireworks
Crabby Apple Fans Unimpressed by Macworld
Cramer's 'Stop Trading!': A Joy Global World
Top 5 Large-Caps for Jan. 7
Transocean Deserves Better Than This
Fed: Contraction to Continue Despite Moves
Children's Place Outpaces GymboreePicking the Right Fixed-Rate MortgageNegotiate Your Credit Card Bill
Try Jim Cramer's Action Alerts PLUS Free!($)
- Trimming a Financial Position (Action Alerts PLUS $)
- Waiting to Increase a Biotech Bet (Action Alerts PLUS $)
- Out of Energy (Action Alerts PLUS $)
- Acting on a Cheap Valuation (Action Alerts PLUS $)
- Selling One, Buying One (Action Alerts PLUS $)
- Looking to Add to This Tech Holding (Action Alerts PLUS $)
- This Holding Is Taking Advantage of a Shift (Action Alerts PLUS $)
- China Can Get It Done (Action Alerts PLUS $)
- Trimming Two Energy Names (Action Alerts PLUS $)
- Increasing My Stake in China (Action Alerts PLUS $)
- Buying a Winning Financial (Action Alerts PLUS $)
- Expect a Busy Year in Pharma (Action Alerts PLUS $)
- Weekly Roundup (Action Alerts PLUS $)
- Investing 101 (Action Alerts PLUS $)
- Booking Profits (Action Alerts PLUS $)
Latest Headlines
- 'Mad Money Lightning Round': Bank With Wells Fargo | Video
- Opinion: Is It Twilight in America?
- Options Market Gears Up for Earnings
-
Cramer: Dow 30 in '09 Playbook, Part II
- Kass: Patience Is a Virtue
- BioMarin Buys Rights to Long-Delayed La Jolla Drug
-
Bernie Bumps Banks from Headlines
-
The Real Story Wrap: January 6
-
Top Ten Most Searched Stocks on TheStreet.com
- Steve Jobs Knows Exactly What He's Doing
-
Jobs-Less Macworld A Bust
- Senate Sworn In, Burris Denied
- Orexigen to Post Obesity Data in Race With Vivus, Arena
- Cisco Bulls Outweigh Bears; Adobe Still A Hot Call
- CKE, Yum, Chipotle Still Plan to Expand
Life & Money
Utah AG: BCS May Violate Antitrust Laws
The Attorney General is investigating the Bowl Championship Series after the University of Utah was snubbed again.
Jim Cramer's Action Alerts PLUS
Trimming a Financial Position
The stock is up significantly from its October-November lows, and it makes sense to take some off.
TheStreet Ratings
TSC Ratings' Updates: Eldorado
Aecom, Deutsche Telekom, Eldorado Gold and Fidelity National are upgraded; Smithfield Foods is downgraded.
Investing A-To-Z
Long-Term Stock Investing Still Works
Even in this bad recession, good companies will outperform over the long haul.
TheStreet Picks
Dividend.com: Devon Downgraded
An analyst says there are concerns about a hedging strategy that could restrict the company's growth.
Stanley Bing
Stock for Stocking Stuffers
At bargain prices, it would be brilliant to stuff stockings with stock certificates, if they existed.
Trimming Two Energy Names (Action Alerts PLUS $)
I am up around 10% in both positions and think it makes sense to take profits.
Kass: Patience Is a Virtue
The S&P 500 is not going to immediately regain a meaningful amount of the lost value of 2008.
BioMarin Buys Rights to Long-Delayed La Jolla Drug
The company has licensed worldwide commercial rights to Riquent, an experimental lupus drug from La Jolla Pharmaceuticals.
The big extravaganza kicks off this week in Las Vegas.
Synovus increased its fourth-quarter loan-loss cushion against higher loan charge-offs to $350 million, $100 million higher than it said on Friday.
Bank of America CEO Ken Lewis is recommending that he and other top executives should not receive bonuses for 2008, as the bank's earnings will be below expectations.
Fortress Investment Group has seen its share price sink to about $1, as it faces a bleak outlook for raising capital and retaining investor redemptions.
For the first time since 2000, passenger-car sales exceed truck sales among U.S. automakers.
The president-elect has provided a few details on his economic recovery plan, but market observers warn that it could be some time before it has an effect on the U.S. economy.
After some early volatility, stocks in New York close Tuesday with gains as investors shake off the latest economic data. Frank Curzio reviews the action in The Real Story video (above).
